Remimazolam induced cytotoxicity mediated through multiple stress pathways and acted synergistically with tyrosine kinase inhibitors in hepatocellular carcinoma
Our findings open up new possibilities for combinatory HCC therapy using remimazolam, leveraging its dual functional roles in surgery and drug therapy for liver cancers.
Authors
- Zhi‐Fu Wu (ORCID: https://orcid.org/0000-0001-6376-9085)
- Shuting Liu (ORCID: https://orcid.org/0000-0001-7581-1498)
- Jia-Tong Lee
- Hou‐Chuan Lai (ORCID: https://orcid.org/0000-0003-4295-3208)
- Jialin Chen (ORCID: https://orcid.org/0000-0002-7519-0545)
- Hsiu‐Lung Fan
- Shih-Ming Huang
Institutions
- Tri-Service General Hospital (TW)
- Kaohsiung Medical University (TW)
- Taipei Medical University (TW)
- National Defense Medical Center (TW)
Publication Details
- Journal
- Redox Report
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1080/13510002.2025.2475696
- Citations
- 3
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 4.41
Funders
- National Science and Technology Council